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Abstract
Ubiquitin-conjugating enzymes (E2s) covalently modify protein substrates with
ubiquitins. The active site cysteine residues on E2s are essential for catalyzing the
transfer of ubiquitin from the E2 active site onto the protein substrate, however there is a
limited amount of information available concerning additional active site residues for E2s
that may also participate in catalysis. Cdc34 is an essential E2 that has merited the lion’s
share of attention for biochemical analysis of the E2 family. Previous phylogenetic
analysis of Cdc34 amino acid sequences has identified an invariably conserved histidine
residue close to the active site cysteine in the primary structure, however whether this
residue actually participates in Cdc34 function is unknown. Here we demonstrate that
histidine 98 on the human Cdc34 ubiquitin conjugating enzyme is vital to the enzymatic
activity of the E2. Recombinant His98Ala mutant Cdc34 was isolated from bacterial cells
engineered to express the protein and compared to wild-type Cdc34 through two
complementary ubiquitination assays. Substitution of the histidine residue with alanine
resulted in a nearly complete loss of function. These results uncover the possible roles
that histidine 98 may play during Cdc34 function.
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Introduction
The ubiquitin proteasome system (UPS) is the single largest pathway in
eukaryotic cells and is responsible for the regulated degradation of proteins.1 There are
three primary reasons why a protein is targeted for degradation. First, proteins become
old and/or damaged over time and must be efficiently disposed of. Secondly, some
proteins do not fold correctly after their translation from ribosomes, and they must be
degraded before they aggregate and perturb normal cellular function. Lastly, some
proteins control various biological processes and when their functions are completed,
their presence may disrupt the cell and thus they also must be removed at this point.
There is great medical relevance to studying the molecular processes of the UPS.
For instance, we now appreciate that when several genes that function in the UPS become
mutated, various forms of cancer can arise.2 Furthermore, a link between malfunction of
the UPS and neurodegenerative disorders has also been made.3 Thus, a greater
appreciation for how proteins in the UPS function may eventually lead to human
therapies. For example, a proteasome inhibitor (note that the proteasome is a
macromolecular protease that binds to and degrades ubiquitinated proteins), Bortezomib,
has been approved by the FDA for the treatment of myeloma, a form of cancer.4
Proteins are targeted for degradation by the covalent attachment of ubiquitin, a
conserved 76 amino acid protein.1 Once a protein is modified by an ubiquitin molecule,
this serves as the site for the addition of more ubiquitins and the eventual formation of a
poly-ubiquitin chain. This is referred to as ubiquitination. This is relevant to proteolysis
because the 26S proteasome (see above) recognizes poly-ubiquitinated proteins that
contain an ubiquitin chain of at least 4 or more protomers.1
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The ubiquitination of a protein substrate of the UPS involves three enzymes: E1,
E2 and E3. The E1, also known as ubiquitin activating enzyme, uses the energy in ATP
to form a high energy covalent intermediate between the E1 active site and the Cterminus of ubiquitin (Fig. 1a). This enzyme then passes this activated ubiquitin to the E2
active site, also known as ubiquitin conjugating enzyme (Fig. 1b). The E2~ubiquitin then
binds to the E3 ubiquitin ligase that recognizes and binds to the protein substrate. The E3
then promotes the transfer of ubiquitin from the E2 to the E3 (Fig. 1c).
Cdc34 is an ubiquitin conjugating enzyme or E2 that has great biological
significance.5 Cdc34 functions with the cullin-RING ligase family of E3s, the most
numerous family in human cells. The mechanism of action of Cdc34 has been under
investigation since the discovery of ubiquitin conjugating enzymes, and thus it is
reasonable to consider Cdc34 the archetypal E2.6
Even though a considerable amount of time has been spent on determining the
molecular mechanism of action of Cdc34, large gaps in our understanding of the details
for how this enzyme works exist. For instance, Cdc34 contains several highly conserved
residues in the active site.7 However, the molecular roles for these residues are, in some
cases, unknown. For instance, human Cdc34 (huCdc34) contains an invariably conserved
histidine residue at position 98 (His 98). Histidine residues are commonly involved in
enzyme mechanisms such as general acid-base catalysis or in the binding of substrate,
however it is unknown whether either or both of these roles pertain to His 98 in
huCdc34.8 The aim of this thesis is to begin a preliminary investigation into the
molecular function of His 98. Here we determine that this residue greatly contributes to
Cdc34 catalysis and our results pave the way for future more detailed mechanistic work.
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Methodology
Constructs and Plasmids: A previously described plasmid, which is designed to express
huCdc34 containing an N-terminal 6-histidine tag for purification in bacteria, was
used as a starting point.10 DNA primers were generated using online software that
introduced a mutation in the huCdc34 DNA sequence that corresponds to the
replacement of histidine at position 98 with alanine.11 A polymerase chain
reaction was assembled from a commercially available kit followed by 22 rounds
of thermal cycling to produce the DNA product.12 This was then digested with 1
μL of Dpn1 restriction enzyme at 37 degrees C for 1 hour, followed by the
transformation of DNA into chemically competent E. coli cells. The plasmid
expressing huCdc34 is also marked by a gene that confers ampicillin resistance,
and therefore bacteria that took up the plasmid were selected for on LB-ampicillin
plates. Single colonies were isolated and grown in selective liquid media
overnight, followed by the purification of plasmid DNA with a commercially
available mini-prep kit.13 The presence of the His98Ala mutation in the huCdc34
amino acid sequence was verified by DNA sequencing.
Protein expression: Expression of a human recombinant protein in bacteria requires using
a special strain of E. coli named Rosetta. This is an engineered strain of bacteria
that has been genetically altered for the efficient expression of recombinant
protein. Plasmids corresponding to either wild-type or His98Ala huCdc34 were
transformed into Rosetta competent bacterial cells and transformants were
selected for on solid LB media with selective antibiotics overnight. Around
twenty colonies were selected and transferred to a liquid LB medium with the
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proper selective antibiotics. The media was incubated in a Thermo MaxQ4000
shaker incubator for approximately twelve hours at 37 degrees C.14 Twenty mL of
the inoculated media was then transferred to a fresh liter of LB plus antibiotics,
which was then incubated in a Thermo MaxQ8000 shaker/incubator at 37 degrees
C.14
The OD600 of the culture was periodically checked to estimate the growth of the
bacteria until it reached approximately 0.8. The bacterial suspension was then
introduced to the presence of 0.4 mM IPTG, which signals the bacteria for the
production of recombinant protein. After approximately 3 hours, the bacteria were
separated from the growth media by centrifuging the suspensions at 5000xG for
ten minutes. The supernatants were discarded, and then 25 mL of phosphatebuffered saline (PBS) was used to wash and re-suspend the pellets.20 These
suspensions were centrifuged again, the supernatants discarded, and their
remaining pellets (containing the bacterial cells) flash frozen using liquid
nitrogen. The frozen cells were then stored in a minus 80 °C freezer for later use.
Protein purification: The bacterial pellets were thawed and suspended in 30 mL of lysis
buffer.14 This suspension was then sonicated at least three times to disrupt the
bacterial cell walls and cellular membranes. The lysates were transferred to
labeled Oakridge tubes and centrifuged at approximately 23,000xG for forty
minutes. The supernatants, which contain both recombinant huCdc34 and
endogenous bacterial protein, were then transferred to 50 mL Falcon™ tubes
containing Nickel-agarose resin that had been pre-washed in lysis buffer. Note
that Nickel-agarose has high affinity for proteins containing the 6-histidine tag
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that was introduced into the recombinant huCdc34 amino acid sequence.21 These
solutions were incubated with agitation for 2 hours at 4 degrees C. The solutions
were then centrifuged at 1000xG to collect the resins, and washed multiple times
with lysis buffer. The washed resins were then transferred to disposable columns
and 2.7 mL of nickel elution buffer was added, which allows for the dissociation
and collection of a solution containing the Cdc34 proteins. This protein solution
was then dialyzed 3X against a storage buffer.15
Enzyme assays: Cdc34 is an ubiquitin conjugating enzyme that joins ubiquitin protomers
into a poly-ubiquitin chain. In living cells, Cdc34 collaborates with the SCF
ubiquitin ligase to build poly-ubiquitin chains onto protein substrates that bind to
SCF. Cdc34 has its own intrinsic activity, which can be measured in the absence
of SCF. Cdc34 activity can also be assessed in the presence of SCF and SCFbound substrate. Both of these assays, named the di-ubiquitin synthesis assay (for
the SCF-independent Cdc34 activity) and the ß-catenin ubiquitination assay (for
SCF-dependent activity) were used to track the rates of ubiquitination for both
wild-type and mutant Cdc34.
Description of the di-ubiquitin synthesis assay (SCF-independent): In this assay, Cdc34 is
pre-incubated with 32P-labeled ubiquitin and purified E1 enzyme (generous gift
from A. Ziemba).18 This forms a thioester bond between Cdc34 and radio-labeled
ubiquitin (shown as Cdc34~ubiquitin hereafter). The reaction was then initiated
by the addition of unlabeled ubiquitin, which resulted in the formation of a
covalent di-ubiquitin product over time. Time-points were taken at various
intervals. The reaction was quenched by the addition of 2X SDS-PAGE (poly-
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acrylamide gel electrophoresis) running buffer, which serves to denature the
native state of the proteins. The products and reactants were separated by SDSPAGE followed by auto-radiography and the quantitation of products and
reactants using a Typhoon image scanner and ImageQuant software.16 The
amount of product is calculated as a percentage of total products and reactants
followed by the normalization of signal to the enzyme concentration. These
values were then plotted in at least duplicate versus time and followed by linear
regression.17 The slope of the line represents the rate of Cdc34 reaction. Thus,
wild-type and His98Ala Cdc34 intrinsic enzyme activity can be quantitatively
compared.
Description of ß-catenin ubiquitination assay (SCF-dependent): In this assay, huCdc34 is
pre-incubated with unlabeled ubiquitin and E1 as before, followed by the addition
of the SCF ubiquitin ligase, and finally the reaction was initiated by adding 5 μM
32

P labeled ß-catenin peptide (kind gift from G. Kleiger).19 Time-points were

taken and products and reactants were separated as above. Note that a product is
considered as a ß-catenin peptide containing one or more ubiquitins. The rate of
ß-catenin ubiquitination was calculated by linear regression as above.
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Results
The basis for understanding the role of His 98 relies on its innate charge and
polarity. Specifically, histidine residues contain an imidazole side-chain that can act as
both a hydrogen bond donor and acceptor. This can both promote the formation of the
enzyme-substrate complex and/or promote catalysis by forming hydrogen bonds that
stabilize the transition state complex. Additionally, histidine residues can act in general
acid-base chemistry. In summary, all of these potential mechanisms may promote Cdc34
activity. As such, if any of these mechanisms are relevant to Cdc34 activity, our
hypothesis is that the His98Ala mutation would have a negative effect on product
formation during Cdc34 catalysis. Since alanine is an uncharged nonpolar amino acid, it
should disrupt all the potential roles for the histidine residue mentioned above. To test
our hypothesis, we generated a His98Ala mutant huCdc34 protein and compared its
activity to wild-type huCdc34 using two specific ubiquitination assays (see methods).
The rate of ubiquitination for His98Ala mutant huCdc34 enzyme was
significantly slower than its wild-type counterpart in both ubiquitination assays. For
instance, in the di-ubiquitin synthesis assay, the rate of product formation for His98Ala
huCdc34 was approximately eleven times slower than for wild-type (0.00165 ± 0.00037
min-1 versus 0.01941 ± 0.004108 min-1, respectively, Fig. 2). Additionally, in the ßcatenin ubiquitination assay, His98Ala huCdc34 was more than 110 times slower (0.0024
± 0.0003 min-1 versus 0.28 ± 0.04 min-1, Fig. 3). In fact, His98Ala huCdc34 activity was
so defective in this assay that product formation was barely apparent, and we had to apply
special techniques to detect the signal for true product over background (see discussion).
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Therefore, these results leave no doubt that His 98 plays a prominent role during the
catalysis of ubiquitination by the huCdc34 ubiquitin conjugating enzyme.
Note that the rate of product formation was estimated by linear regression
(methods). The data fit extremely well to a linear model as evidenced by the statistical
significance of the R2 values for the goodness of fit being close to 1. Furthermore, the
standard error of measurement (SEM) was estimated during the fitting procedure and was
based on at least duplicate data points for all results. These SEM values are provided next
to the rates of product formation (shown in the inset next to the graphs in Figs. 2 and 3).
Notice that the errors are substantially lower than the estimates for the rates of the
reactions. Some concern might be drawn over the high SEM values associated with the
rates for His98Ala huCdc34 in both ubiquitination assays. This would initially create a
large uncertainty as to the statistical significance of the mutant Cdc34 ubiquitination
rates. However, note that the rate of product formation is negligible compared to its wildtype counterpart and easily identifiable from the autoradiographs, such that the difference
between the wild-type and His98Ala rates far outweighs the large SEM values for mutant
huCdc34.

9

Discussion
We determined that the His 98 residue in huCdc34 is crucial for the mechanism of
catalysis during the ubiquitination reaction. There are several potential explanations for
why this could be so. First, His 98 could be forming a hydrogen bond with the ubiquitin
substrate. This could serve to orient the lysine on the ubiquitin (note that ubiquitin has
seven potential lysine acceptors on its surface).9 In fact, Cdc34 is known to catalyze
ubiquitin chains where Lys 48 is the preferred acceptor during chain formation.6 Perhaps
His 98 forms a hydrogen bond with ubiquitin during this reaction to thus orient Lys 48 in
the active site to promote its iso-peptide bond formation with Cdc34~ubiquitin. Second,
His 98 could be forming a hydrogen bond with the transition state conformation of the
substrate. A tetrahedral intermediate during iso-peptide bond formation is known to occur
during the E2 catalytic cycle. This could involve an H-bond between His 98 and the
oxyanion that forms in the transition state complex, which would serve to lower the
transition state energy and therefore the activation energy barrier. Finally, we can also
envision a role for H98 in acid-base catalysis. For instance, the acceptor lysine on either
SCF-bound substrate or on ubiquitin must be deprotonated before it can participate in a
nucleophilic reaction. The basic imidazole side-chain of histidine could theoretically
deprotonate lysine.
Several complications arose during the quantitation of His98Ala huCdc34 for the
ß-catenin ubiquitination assay, and novel methods had to be developed to overcome this
temporary hurdle. One of the earliest obstacles encountered involved the radioactivity of
the 32P-labeled ß-catenin. Due to this isotope’s relatively short half-life (approximately 14
days), the signal for the images during autoradiography was very weak. Therefore,
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autoradiography with a phosphor screen, which normally needs only one hour of
exposure, under these conditions involved timing the experiments so that the gels could
be exposed overnight. This new technique, although it introduced more background
interference and the potential oversaturation of signals from substrate, was essential in
quantitating the faint product bands for the ß-catenin ubiquitination assay and His98Ala
mutant Cdc34.
Another problem with His98Ala mutant huCdc34 quantitation arose from its
inherent deficiency in ubiquitin conjugation. Even with a longer exposure time on the
phosphor screen, the faintness of the product bands made it such that the background
noise significantly interfered with the detection of product. This initially resulted in an
extremely low R2 (<0.3) using a typical procedure for background correction. We
circumvented the problem by performing individual background corrections for each
product band. These two techniques allowed for the quantitation, albeit with a significant
amount of error, of the results for His98Ala Cdc34 from the β-catenin ubiquitination
assay.
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Conclusion
Here we conclusively demonstrate that His 98 is vital to huCdc34’s enzymatic
activity. Since this histidine is conserved among all eukaryotic Cdc34 orthologs, it is
reasonable to assume that the residue contributes to the functions of all Cdc34 proteins
from all eukaryotic organisms. Although the actual mechanistic role is still unknown, we
note that there are several interesting possibilities. Our results pave the way for more
sophisticated biochemical approaches that can uncover the exact mechanism of action for
how this histidine residue functions in the Cdc34 enzyme.
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Figures and Tables

1A.

1B.

1C.

Figure One: The ubiquitination of a protein substrate involves the sequential
action of three classes of enzymes: E1, E2 and E3. (A) The E1 enzyme binds to ubiquitin
and ATP and promotes the formation of a high energy thioester bond intermediate
between the C-terminal end of ubiquitin and the E1 active site cysteine residue. (B) The
E2 enzyme binds to the E1~ubiquitin and the ubiquitin is transferred to the E2 active site
cysteine. (C) The E3 binds to both the protein substrate that is to be modified and to the
E2~ubiquitin, which promotes the transfer of ubiquitin from the E2 to the protein
substrate.
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2A: Di-ubiquitin synthesis assay for wild-type huCdc34.

2B: Plot of 2A.
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2C: Di-ubiquitin synthesis assay for His98Ala mutant huCdc34.

2D: Plot of 2C.
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Figure Two: Results for the comparison of wild-type and His98Ala Cdc34 using
the di-ubiquitin synthesis assay. (A) Autoradiograph showing the formation of product
for wild-type Cdc34 over time. Note the increasing amount of di-ubiquitin (product)
shown over time. (B) Graph showing the amount of di-ubiquitin normalized for Cdc34
concentration over time. Linear regression was used to determine the line of best fit to the
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data. (C) Same as in (A) except using His98Ala Cdc34. (D) Same as in (B) except using
His98Ala Cdc34 (Ub is ubiquitin).
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3A: Beta-catenin ubiquitination assay for wild-type huCdc34.

3B: Plot of 3A.
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3C: Beta-catenin ubiquitination assay for His98Ala huCdc34.

3D: Plot of 3C.
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Figure Three: Results for the comparison of wild-type and His98Ala Cdc34
using the β-catenin ubiquitination assay. (C) While it is difficult to detect the formation
of product by eye from the autoradiogram, notice that the increase in product is easily
perceptible through computational quantitation (D).
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Table One: Wild-type huCdc34 in duplicate for the di-ubiquitin reaction.

Time (m)

WT huCdc34 WT huCdc34

3.

0.04781488

0.08477971

6.

0.09041639

0.149125

9.

0.1460612

0.2271989

12.

0.1972842

0.2788746

Table Two: His98Ala Mutant huCdc34 in duplicate for the di-ubiquitin reaction.

Time (m)

His98Ala huCdc34

His98Ala huCdc34

10.

0.01682636

0.01230089

20.

0.0371301

0.0246475

40.

0.08405849

0.04633586

70.

0.1498405

0.07737828
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Table Three: Wild-type huCdc34 in duplicate for the ß-catenin reaction.

Time (m)

WT huCdc34 WT huCdc34

4.

2.240333

2.466434

6.

2.944260

3.263175

8.

3.254951

3.916962

10.

3.764723

4.987077

20.

5.737291

8.126178

Table Four: His98Ala mutant huCdc34 in duplicate for the ß-catenin reaction. Note the
nullification of the first time-point to achieve a linear result.

Time (m)

His98Ala huCdc34

His98Ala huCdc34

10.

0.000000

0.000000

30.

0.05646447

0.05801594

60.

0.07365134

0.09258923

90.

0.1599235

0.1302997

120.

0.3201147

0.2499201

All table data were generated using the following equation:

21

Acknowledgements
Special thanks to Dr. Gary Kleiger, Amy Ziemba, Spencer Hill, Daniella Sandoval,
Casey Hall, and Shirley Shen for their outstanding help with this project.

22

